Concepedia

Hao Zeng

HZ

Statistics

Publications

23

Citations

724

H-Index

16

Active since

2016

Affiliations

China Pharmaceutical University(Current)

Sichuan University

West China Hospital of Sichuan University

Army Medical University

Zhongnan Hospital of Wuhan University

Hao Zeng is an author at China Pharmaceutical University specializing in life sciences, pharmacology, and inflammation.

ORCID

Publications per year

2016–2025

23

Publications

23

Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response

Hao Zeng, Ting Pan, Meiling Zhan et al. · Signal Transduction and Targeted Therapy · 2022 · 112 citations · Full text

, , +17

Lactate activates trained immunity by fueling the tricarboxylic acid cycle and regulating histone lactylation

Huanhuan Cai, Xueyuan Chen, Yan Liu et al. · Nature Communications · 2025 · 72 citations · Full text

, , +17

Activated PKB/GSK-3β synergizes with PKC-δ signaling in attenuating myocardial ischemia/reperfusion injury via potentiation of NRF2 activity: Therapeutic efficacy of dihydrotanshinone-I

Hao Zeng, Lingling Wang, Jiawei Zhang et al. · Acta Pharmaceutica Sinica B · 2020 · 68 citations · Full text

, , +17

HIF-1α Preconditioning Potentiates Antioxidant Activity in Ischemic Injury: The Role of Sequential Administration of Dihydrotanshinone I and Protocatechuic Aldehyde in Cardioprotection

Lifeng Jiang, Hao Zeng, Ni LiHong et al. · Antioxidants and Redox Signaling · 2019 · 58 citations

, , +17

Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects

Shilei Xu, Ke‐Qiong Deng, Chengbo Lu et al. · Metabolism · 2024 · 51 citations

, , +14

1–5 of 23